We are live on
!
Find out more
TSW
Thompson Siegel & Walmsley Portfolio holdings
AUM
$5.7B
1-Year Est. Return
6.69%
This Fund
S&P 500
This Quarter
Est. Return
-10.93%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$6.22B
AUM Growth
-$809M
(-12%)
Cap. Flow
+$34.6M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
653
New
17
Increased
117
Reduced
244
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HF Sinclair
DINO
|
+$63.2M |
| 2 |
Olin
OLN
|
+$58.7M |
| 3 |
Warner Bros
WBD
|
+$53.8M |
| 4 |
AerCap
AER
|
+$46.4M |
| 5 |
X
US Steel
X
|
+$44.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$95.1M |
| 2 |
Viatris
VTRS
|
+$40.4M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$38.4M |
| 4 |
CenterPoint Energy
CNP
|
+$33.9M |
| 5 |
Kraft Heinz
KHC
|
+$29.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.92% |
| 2 | Technology | 11.77% |
| 3 | Communication Services | 11.25% |
| 4 | Healthcare | 9.95% |
| 5 | Industrials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
AstraZeneca
AZN
$263B
| $382K | 0.01% |
2,895
-3,750
| -56% | -$492K |
|
302
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $377K | 0.01% |
2,914
+192
| +7% | +$27.2K |
|
303
GE Aerospace
GE
$374B
| $376K | 0.01% |
9,473
-337
| -3% | -$16.3K |
|
304
Cadence Design Systems
CDNS
$93.6B
| $360K | 0.01% |
2,400
| – | – |
|
305
Textron
TXT
$14.7B
| $355K | 0.01% |
5,806
| – | – |
|
306
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $346K | 0.01% |
8,637
-5,209
| -38% | -$219K |
|
307
Cummins
CMI
$87.5B
| $333K | 0.01% |
1,720
-16
| -0.9% | -$3.2K |
|
308
Robert Half
RHI
$3.87B
| $320K | 0.01% |
4,270
-101
| -2% | -$9.58K |
|
309
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
| $314K | 0.01% |
3,323
+2,373
| +250% | +$242K |
|
310
Planet Labs
PL
$7.3B
| $312K | 0.01% |
72,000
| – | – |
|
311
Baxter International
BAX
$13.5B
| $310K | 0.01% |
4,821
-420
| -8% | -$30.5K |
|
312
PNC Financial Services
PNC
$99.7B
| $306K | ﹤0.01% |
1,938
-107
| -5% | -$17.9K |
|
313
The ONE Group
STKS
$56.2M
| $304K | ﹤0.01% |
41,183
+1,535
| +4% | +$14K |
|
314
Universal Corp
UVV
$1.31B
| $302K | ﹤0.01% |
5,000
| – | – |
|
315
Abbott
ABT
$183B
| $301K | ﹤0.01% |
2,766
-3,144
| -53% | -$357K |
|
316
Yum China
YUMC
$16.5B
| $295K | ﹤0.01% |
6,077
| – | – |
|
317
Medtronic
MDT
$109B
| $286K | ﹤0.01% |
3,190
-324
| -9% | -$32.8K |
|
318
iShares Core S&P 500 ETF
IVV
$878B
| $273K | ﹤0.01% |
721
| – | – |
|
319
Nike
NKE
$61.9B
| $267K | ﹤0.01% |
2,610
| – | – |
|
|
TBHC
320
DELISTED
The Brand House Collective
TBHC
| $263K | ﹤0.01% |
74,761
-311,976
| -81% | -$2M |
|
321
CSX Corp
CSX
$93.4B
| $260K | ﹤0.01% |
8,963
-16
| -0.2% | -$522 |
|
|
HOLX
322
DELISTED
Hologic
HOLX
| $259K | ﹤0.01% |
3,731
| – | – |
|
323
American Tower
AMT
$80.8B
| $253K | ﹤0.01% |
988
| – | – |
|
324
McDonald's
MCD
$192B
| $244K | ﹤0.01% |
990
-910
| -48% | -$224K |
|
325
NextEra Energy
NEE
$181B
| $241K | ﹤0.01% |
3,116
-3,390
| -52% | -$258K |
|
Similar funds
PI
ACM
VH
O
XT
DCP
HW
AAM
Thompson Siegel & Walmsley's Q2 2022 Portfolio in Review
As of Q2 2022, Thompson Siegel & Walmsley held 653 positions worth $6.22B, down 12% from $7.03B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Thompson Siegel & Walmsley's Q2 2022 filing shows 17 new, 117 increased, 244 reduced and 84 closed positions. Its largest new stake was HF Sinclair: 1,410,776 shares worth $63.7M. The largest sale was CDK Global, Inc., an estimated $95.1M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Communication Services.
- Thompson Siegel & Walmsley's largest Q2 2022 buy was HF Sinclair: 1,410,776 shares worth $63.7M.
- Thompson Siegel & Walmsley added most to Olin in Q2 2022, an estimated $58.7M increase.
- Thompson Siegel & Walmsley's biggest Q2 2022 reduction was CDK Global, Inc., cutting an estimated $95.1M.
- Thompson Siegel & Walmsley fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $38.4M.
- Thompson Siegel & Walmsley's ten largest holdings make up 17% of its $6.22B portfolio in Q2 2022.
- Thompson Siegel & Walmsley opened 17 new positions and closed 84 in Q2 2022.
- Thompson Siegel & Walmsley's portfolio value fell 12% quarter-over-quarter to $6.22B.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2022, filed 22 Jul 2022.